PFF Summit 2019 CME/MOC

CME/MOC Information

Jointly provided by Postgraduate Institute for Medicine and the Pulmonary Fibrosis Foundation, in collaboration with Global Academy for Medical Education.



This activity is not supported by any educational grants.


Target Audience: This activity is intended for physicians, physician’s assistants, respiratory therapists, pharmacists, nurse practitioners, and registered nurses engaged in the care of patients with pulmonary fibrosis.


Educational Objectives: After completing this activity, the participant should be better able to:

  • Explain the pathophysiology of IPF based on the most current data
  • Accurately diagnose IPF using a systematic approach
  • Effectively implement key diagnostic procedures including HRCT scanning and surgical lung biopsy
  • Discuss recent evidence for treatments in the management of IPF
  • Recognize genetic components of IPF
  • Describe the role of lung transplantation in IPF, and the factors that affect candidacy and timing
  • Provide patient lifestyle management tools which improve functional status
  • Develop a comprehensive approach to the management of IPF, that includes both pharmacologic and non-pharmacologic therapies


Physician Continuing Medical Education:  The Postgraduate Institute for Medicine designates this live activity for a maximum of 20.5 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.5 MOC points [and patient safety MOC credit] in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. A 10 question post-test will be required in order to obtain MOC credit. See the section below for “Request for credit” for more detail.


To claim and receive MOC credits, learners must follow the Request for Credit instructions and provide:

  • ABIM ID number
  • first and last name
  • degree and specialty
  • DOB (month and day)

Continuing Pharmacy Education
:  Postgraduate Institute for Medicine designates this continuing education activity for 20.5 contact hour(s) (0.205 CEUs) of the Accreditation Council for Pharmacy Education.

Nurses and Allied Health Network

(Universal Activity Number - JA4008162-9999-19-950-L01-P)

Translational Genomics: The Future is Now

(Universal Activity Number - JA4008162-9999-19-951-L01-P)


(Universal Activity Number - JA4008162-9999-19-953-L01-P)

Pulmonary Fibrosis Registries and Resources: What is in them and what have we learned and

where are we going

(Universal Activity Number - JA4008162-9999-19-954-L01-P)

IPF Diagnostics

(Universal Activity Number - JA4008162-9999-19-955-L01-P)

Clinical Trials: Empowering Patients to Participate

(Universal Activity Number - JA4008162-9999-19-956-L01-P)


(Universal Activity Number - JA4008162-9999-19-957-L01-P)

Autoimmune ILD and Chronic Hypersensitivity Pneumonitis (CHP)

(Universal Activity Number - JA4008162-9999-19-958-L01-P)

Therapeutic Challenges and Controversies in ILD

(Universal Activity Number - JA4008162-9999-19-961-L01-P)

Type of Activity: Knowledge


Pharmacists have up to 30 days to follow the Request for Credit instructions - complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.


Continuing Nursing Education:  The maximum number of hours awarded for this Continuing Nursing Education activity is 20.4 contact hours.


Continuing Respiratory Care Education (CRCE):  This program has been approved for 16.41 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425, N. MacArthur Blvd, Suite 100, Irving TX 75063.


Disclosure of Conflicts of Interest:  Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Faculty:  All disclosures will be available for review in the Speaker Ready Room.


Planners and Managers: The PIM planners and managers have nothing to disclose. The Pulmonary Fibrosis Foundation and Global Academy for Medical Education planners and managers have nothing to disclose.


Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Request for Credit: If you wish to receive acknowledgment for completing this activity, please complete the evaluation on On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13954. Upon registering and completing the activity evaluation, your certificate will be made available immediately. 


For Pharmacists:  Please complete the evaluation on On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 13954. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service.


Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly.  If you need to obtain your NABP e-Profile, please visit